New Cannabis Extract Law Amended by DEA
The DEA on Wednesday set tighter regulations for marijuana extracts, including cannabidiol (CBD.) The United States’ Drug Enforcement Administration (DEA) set new Cannabis extract laws by amending the Schedule 1 Controlled Substances Act.
In the new drug code titled “Establishment of a New Drug Code for Marihuana Extract,” the DEA says it is “creating a separate code number for marihuana extract with the following definition: ‘Meaning an extract containing one or more cannabinoids that has been derived from any plant of the genus Cannabis, other than the separated resin (whether crude or purified) obtained from the plant.’ Extracts of marihuana will continue to be treated as Schedule I controlled substances.”
This means CBD and all other extracts derived from the cannabis plant (psychoactive or not) will come under Schedule 1 drugs, like heroin, LSD, marijuana, and ecstasy, and cannot cross state lines. Any person currently licensed to produce and handle marijuana extracts is required to apply for a modification of their registration by Jan. 13, 2017, the new document says.
Full Story can be found here: https://www.yahoo.com/news/cbd-now-schedule-drug-dea-083035386.html